Development and Characterization of Madecassoside-Loaded Ultra-Small Unilamellar Vesicles for Enhanced Transdermal Anti-Keloids
Penulis / Author
Detail Publikasi
International Journal of Applied Pharmaceutics
Innovare Academic Sciences
18
5
389–397
0975-7058
Abstrak
Objective: This study aimed to develop and characterize madecassoside-loaded ultra-small unilamellar vesicles (USUV) to improve transdermal delivery of madecassoside for potential anti-keloid treatment. Methods: Madecassoside-loaded USUV were formulated using virgin coconut oil (VCO), soy lecithin, and Tween 80 through a sonication-assisted emulsification technique. Three oil-phase variants (VCO, olive oil, and caprylic/capric triglyceride) were evaluated. The optimized formulation was characterized for particle size by dynamic light scattering (DLS), polydispersity index (PDI), zeta potential, entrapment efficiency (EE) by indirect UV-Visible spectrophotometry, and physicochemical stability by freeze-thaw cycling. Vesicle morphology was assessed by transmission electron microscopy (TEM). In vitro permeation was conducted using Franz diffusion cells with cellulose acetate (0.45 µm) and polycarbonate (0.1 µm) membranes under sink conditions. Results: VCO-based USUV demonstrated superior physicochemical characteristics (ANOVA, p<0.05): particle size 10.48±0.25 nm, PDI 0.186±0.007, peak intensity 96.9±0.3%, and zeta potential −33.3±1.65 mV. The optimized madecassoside-loaded USUV exhibited a mean particle size of 10.33 nm, PDI 0.175, zeta potential −31.3 mV, and EE 80.33% with spherical nano-vesicular morphology. Physicochemical stability was maintained across three freeze-thaw cycles. In vitro permeation followed apparent zero-order kinetics; steady-state flux (Jss) derived from regression slope was 0.622±0.047 µg/cm²/min (cellulose acetate) and 0.477±0.052 µg/cm²/min (polycarbonate). Permeability coefficients (Kp) were 6.240±0.480 cm/h and 4.800±0.540 cm/h, respectively (p<0.05). Conclusion: Madecassoside-loaded USUV exhibited favorable physicochemical properties, high encapsulation efficiency, and enhanced transdermal permeation. These findings suggest USUV as a promising nanocarrier for dermal delivery of madecassoside in keloid therapy. Further in vivo and clinical studies are required to validate therapeutic efficacy.
Dana Insentif
B.2 - (Q2) WOS IF 0,5-0,9
Rp 20.000.000
Dana Disetujui
Rp 20.000.000
Dicairkan
04 Nov 2026
Alur Proses
Klaim Diajukan
16 Sep 2026Verifikasi Fakultas
17 Sep 2026Verifikasi Rektorat
12 Oct 2026Verifikasi Sekretaris
25 Sep 2026Disetujui Ka LPPM
25 Sep 2026Dana Dicairkan
04 Nov 2026Informasi Dosen
Ully Chairunisa
NIDN: 1017118805
Asisten Ahli
Profil Akademik